Euro Roundup: Swissmedic updates responsible person document, asks for immediate action - Regulat...

Euro Roundup: Swissmedic updates responsible person document, asks for immediate action  Regulatory Focus

Swissmedic moves more slowly in reviewing medicines - The Pharma Letter

Swissmedic moves more slowly in reviewing medicines  The Pharma Letter

swissdamed: Deadline on 13 November 2024 - Swissmedic

swissdamed: Deadline on 13 November 2024  Swissmedic

Switzerland Mutual Recognition Agreement - FDA.gov

Switzerland Mutual Recognition Agreement  FDA.gov

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory...

Regulatory Challenges: Is a Surrogate End Point Instead of Overall Survival Enough for Regulatory Approval of (Neo)Adjuvant Cancer Treatment? The Swissmedic Perspective  ASCO Journals

Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin) - Business Wire

Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin)  Business Wire

Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs...

Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs: experiences of the WHO and Swissmedic  Frontiers

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections - SWI swissinfo.ch in En...

Switzerland warns against using ‘Lemon Bottle’ fat-dissolving injections  SWI swissinfo.ch in English

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility ...

Swissmedic Grants Good Manufacturing Practice Multi-Product License to Biogen Biologics Facility in Solothurn, Switzerland  Biogen | Investor Relations

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution -...

Swissmedic issues warning about the illegal medicinal product "Lemon Bottle" lipolysis solution  Swissmedic

Eva von Mühlenen - Sidley Austin LLP

Eva von Mühlenen  Sidley Austin LLP

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Asso...

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data  Wiley Online Library

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic - Reuters.com

No indication of risk due to COVID-19 booster shot bubbles -Swissmedic  Reuters.com

Linnea SA Receives Swiss Narcotics License allowing for the - GlobeNewswire

Linnea SA Receives Swiss Narcotics License allowing for the  GlobeNewswire

Euro Roundup: Swissmedic revises four medicines authorization guidances - Regulatory Focus

Euro Roundup: Swissmedic revises four medicines authorization guidances  Regulatory Focus

LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland - Business ...

LEO Pharma’s Anzupgo® (delgocitinib) Cream Achieves Marketing Approval in Switzerland  Business Wire

Swissmedic updates adverse event reporting requirements for 2024 - Regulatory Focus

Swissmedic updates adverse event reporting requirements for 2024  Regulatory Focus

Euro Roundup: Swissmedic reorganizes to clarify medical device and market surveillance responsibi...

Euro Roundup: Swissmedic reorganizes to clarify medical device and market surveillance responsibilities  Regulatory Focus

Klinische Prüfungen mit Medizinprodukten - Swissmedic

Klinische Prüfungen mit Medizinprodukten  Swissmedic

Switzerland ‘unfortunately’ still awaiting AstraZeneca COVID-19 vaccine data - official - Reuters...

Switzerland ‘unfortunately’ still awaiting AstraZeneca COVID-19 vaccine data - official  Reuters.com

What’s Happening in the UK and Switzerland - MedTech Intelligence

What’s Happening in the UK and Switzerland  MedTech Intelligence

Hemophilia B gene therapy Hemgenix approved in Switzerland - Hemophilia News Today

Hemophilia B gene therapy Hemgenix approved in Switzerland  Hemophilia News Today

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

Switzerland: Revision of Narcotics Act – Switzerland fully legalizes medicinal cannabis - GlobalC...

Switzerland: Revision of Narcotics Act – Switzerland fully legalizes medicinal cannabis  GlobalComplianceNews

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal p...

Operation Pangea XVI: International campaign against falsified and illegally imported medicinal products  Swissmedic

VMD and Swissmedic agree collaboration on veterinary medicinal products - GOV.UK

VMD and Swissmedic agree collaboration on veterinary medicinal products  GOV.UK

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal pr...

Operation PANGEA XV: International campaign against falsified and illegally imported medicinal products  Swissmedic

Journey of blood - Visible - Swissmedic

Journey of blood - Visible  Swissmedic

Swissmedic and the Korean regulatory authority extend their cooperation in the area of therapeuti...

Swissmedic and the Korean regulatory authority extend their cooperation in the area of therapeutic products  Swissmedic

Inadequate monitoring - Public Eye

Inadequate monitoring  Public Eye

Medicines regulators weigh hope and hype with new Alzheimer’s drugs - SWI swissinfo.ch in English

Medicines regulators weigh hope and hype with new Alzheimer’s drugs  SWI swissinfo.ch in English

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

Swiss regulator approves Roche-Regeneron Covid-19 drug - SWI swissinfo.ch in English

Swiss regulator approves Roche-Regeneron Covid-19 drug  SWI swissinfo.ch in English

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the...

CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI® (sparsentan) for the treatment of IgA Nephropathy  PR Newswire UK

Cannabis for medical purposes - Visible - Swissmedic

Cannabis for medical purposes - Visible  Swissmedic

Swissmedic’s enquiry team - Visible - Swissmedic

Swissmedic’s enquiry team - Visible  Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

Incomplete data stalls Swiss authorisation of Covid-19 vaccines - SWI swissinfo.ch in English

Incomplete data stalls Swiss authorisation of Covid-19 vaccines  SWI swissinfo.ch in English

Meet René: The IDF’s First Ever Swiss-Bedouin Medic - idf.il

Meet René: The IDF’s First Ever Swiss-Bedouin Medic  idf.il

Bubbles in Covid booster vials pose no risk: Swissmedic - SWI swissinfo.ch in English

Bubbles in Covid booster vials pose no risk: Swissmedic  SWI swissinfo.ch in English

First Covid-19 vaccine approved for Swiss use - SWI swissinfo.ch in English

First Covid-19 vaccine approved for Swiss use  SWI swissinfo.ch in English

Committed to the next generation - Swissmedic

Committed to the next generation  Swissmedic

MHRA and Swissmedic pledge greater collaboration - PMLiVE

MHRA and Swissmedic pledge greater collaboration  PMLiVE

Interview with Swissmedic Agency Council Chair Lukas Bruhin - Swissmedic

Interview with Swissmedic Agency Council Chair Lukas Bruhin  Swissmedic

Falsified Ozempic diabetes medication in circulation - Swissmedic

Falsified Ozempic diabetes medication in circulation  Swissmedic

Minergie/sustainability - Visible - Swissmedic

Minergie/sustainability - Visible  Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic - Swissmedic

Interview with Raimund Bruhin, Executive Director of Swissmedic  Swissmedic

Improving international collaboration – MHRA and Swissmedic sign MoU - GOV.UK

Improving international collaboration – MHRA and Swissmedic sign MoU  GOV.UK

Switzerland approves vaccine that targets two Covid variants - SWI swissinfo.ch in English

Switzerland approves vaccine that targets two Covid variants  SWI swissinfo.ch in English

Moderna Covid vaccine approved for use in Switzerland - SWI swissinfo.ch in English

Moderna Covid vaccine approved for use in Switzerland  SWI swissinfo.ch in English

A voice for patients - Swissmedic

A voice for patients  Swissmedic

Report exposes widespread hygiene issues in Swiss hospitals - SWI swissinfo.ch in English

Report exposes widespread hygiene issues in Swiss hospitals  SWI swissinfo.ch in English

Switzerland’s drug approval process lags behind Europe - SWI swissinfo.ch in English

Switzerland’s drug approval process lags behind Europe  SWI swissinfo.ch in English

Side effects of COVID-19 vaccines in Switzerland – update - Swissmedic

Side effects of COVID-19 vaccines in Switzerland – update  Swissmedic

The work of the VMEC - Visible - Swissmedic

The work of the VMEC - Visible  Swissmedic

Swiss animals can be vaccinated against bluetongue - SWI swissinfo.ch in English

Swiss animals can be vaccinated against bluetongue  SWI swissinfo.ch in English

Emergency vaccine approval not legal option in Switzerland - SWI swissinfo.ch in English

Emergency vaccine approval not legal option in Switzerland  SWI swissinfo.ch in English

Breakthrough Alzheimer’s drug produced in Switzerland - SWI swissinfo.ch in English

Breakthrough Alzheimer’s drug produced in Switzerland  SWI swissinfo.ch in English

Interacting with social channels - Swissmedic

Interacting with social channels  Swissmedic

Covid-19: Swiss authorities disagree on vaccine-related mortality data - SWI swissinfo.ch in English

Covid-19: Swiss authorities disagree on vaccine-related mortality data  SWI swissinfo.ch in English

Illegally imported medicinal products: underestimated risks! - Swissmedic

Illegally imported medicinal products: underestimated risks!  Swissmedic

Swissmedic authorises new drug for respiratory disease - SWI swissinfo.ch in English

Swissmedic authorises new drug for respiratory disease  SWI swissinfo.ch in English

SwissMedic Approves Abraxane for Metastatic Breast Cancer - Breast Cancer News

SwissMedic Approves Abraxane for Metastatic Breast Cancer  Breast Cancer News

Swiss implant makers come under the microscope - SWI swissinfo.ch in English

Swiss implant makers come under the microscope  SWI swissinfo.ch in English

Gaps found in opioid prescription oversight in Switzerland - SWI swissinfo.ch in English

Gaps found in opioid prescription oversight in Switzerland  SWI swissinfo.ch in English

'Sitting ducks': Volunteer describes rescue at besieged Kenyan hotel - Yahoo Singapore News

'Sitting ducks': Volunteer describes rescue at besieged Kenyan hotel  Yahoo Singapore News

Market surveillance - Visible - Swissmedic

Market surveillance - Visible  Swissmedic

First person dies in Dutch-designed assisted suicide capsule; Journalist arrested - NL Times

First person dies in Dutch-designed assisted suicide capsule; Journalist arrested  NL Times

Large haul of fake erectile stimulants seized - SWI swissinfo.ch in English

Large haul of fake erectile stimulants seized  SWI swissinfo.ch in English

The Shady Business Of Experimental Stem Cell Treatments - Worldcrunch

The Shady Business Of Experimental Stem Cell Treatments  Worldcrunch

Mac-Chem announces successful renewal of its EU-GMP certification for Boisar manufacturing facili...

Mac-Chem announces successful renewal of its EU-GMP certification for Boisar manufacturing facility  ETHealthWorld

Swissmedic identifies dangerous substances in slimming products claimed to be herbal - Swissmedic

Swissmedic identifies dangerous substances in slimming products claimed to be herbal  Swissmedic

Swissmedic identifies dangerous substances in slimming products claimed to be herbal - Swissmedic

Swissmedic identifies dangerous substances in slimming products claimed to be herbal  Swissmedic

Swiss doctors warn against sleep gummy bear trend - Le News

Swiss doctors warn against sleep gummy bear trend  Le News

Swissmedic stoppt Auslieferung von Novartis-Grippeimpfstoff - Neue Zürcher Zeitung - NZZ

Swissmedic stoppt Auslieferung von Novartis-Grippeimpfstoff  Neue Zürcher Zeitung - NZZ